ProKidney
PROK
61 hedge funds and large institutions have $72.2M invested in ProKidney in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 19 closing their positions.
64% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 14
5.28% less ownership
Funds ownership: 65.71% → 60.44% (-5.3%)
8% less funds holding
Funds holding: 66 → 61 (-5)
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
61% less capital invested
Capital invested by funds: $185M → $72.2M (-$113M)
86% less call options, than puts
Call options by funds: $1K | Put options by funds: $7K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$26M |
| 2 |
Millennium Management
New York
|
+$910K |
| 3 |
Squarepoint
New York
|
+$445K |
| 4 |
Renaissance Technologies
New York
|
+$257K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$241K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCG
Social Capital Group
Menlo Park,
California
|
-$53M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$1.65M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$842K |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
-$795K |
| 5 |
Swiss National Bank
Zurich,
Switzerland
|
-$304K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Envestnet Asset Management
Chicago,
Illinois
| – | -$61.1K | -13,340 | Closed |
|
|
MLICM
77
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$15.7K | -3,429 | Closed |
|
78
US Bancorp
Minneapolis,
Minnesota
| – | -$9.62K | -2,101 | Closed |
|
79
Simplex Trading
Chicago,
Illinois
| – | -$255 | -119 | Closed |
|
80
Allspring Global Investments
Charlotte,
North Carolina
| – | -$325 | -71 | Closed |
|
PROK Hedge Fund Activity: Q4 2023 in Review
61 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q4 2023, worth a combined $72.2M — down 61% from $185M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of PROK and 14 opened new positions — a net loss of 5 holders — while 14 trimmed existing stakes and 23 added.
The largest buyer was Morgan Stanley, adding an estimated $26M. The largest seller was Social Capital Group, exiting entirely with an estimated $53M sold.
- 61 institutional investors held ProKidney (PROK) as of Q4 2023, down from 66 in Q3 2023.
- Funds reported $72.2M of ProKidney stock for Q4 2023, down 61% quarter-over-quarter.
- 14 funds opened new ProKidney positions in Q4 2023 and 19 closed out, a net change of -5 holders.
- The largest ProKidney buyer in Q4 2023 was Morgan Stanley, an estimated $26M added.
- The largest ProKidney seller in Q4 2023 was Social Capital Group, an estimated $53M sold.
Based on aggregated 13F filings for Q4 2023.